cyc 202 has been researched along with isopentenyladenosine in 5 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (isopentenyladenosine) | Trials (isopentenyladenosine) | Recent Studies (post-2010) (isopentenyladenosine) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 318 | 1 | 115 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Détivaud, L; Doerig, C; Gray, N; Meijer, L | 1 |
| Doerig, C; Gray, N; Harmse, L; Havlik, I; Leclerc, S; Meijer, L; Schultz, P; van Zyl, R | 1 |
| Koca, J; Kríz, Z; Otyepka, M | 1 |
| Blagoeva, E; Gaudinová, A; Malbeck, J; Vanek, T; Vanková, R | 1 |
| Bártová, I; Koca, J; Kríz, Z; Otyepka, M | 1 |
1 review(s) available for cyc 202 and isopentenyladenosine
| Article | Year |
|---|---|
ATP-site directed inhibitors of cyclin-dependent kinases.
Topics: Adenine; Adenosine Triphosphate; Amino Acid Sequence; Antineoplastic Agents; Binding Sites; Cell Cycle; Cyclin-Dependent Kinases; Drug Design; Enzyme Inhibitors; Flavonoids; Humans; Isopentenyladenosine; Kinetin; Molecular Sequence Data; Piperidines; Purines; Roscovitine; Sequence Alignment; Sequence Homology, Amino Acid; Staurosporine; Suramin | 1999 |
4 other study(ies) available for cyc 202 and isopentenyladenosine
| Article | Year |
|---|---|
Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum.
Topics: Adenine; Animals; Antimalarials; Cell Cycle; Dose-Response Relationship, Drug; Isopentenyladenosine; Kinetin; Parasitic Sensitivity Tests; Phosphotransferases; Plasmodium falciparum; Purines; Roscovitine; Structure-Activity Relationship | 2001 |
Dynamics and binding modes of free cdk2 and its two complexes with inhibitors studied by computer simulations.
Topics: Adenine; Binding Sites; Computer Simulation; Crystallography, X-Ray; Cyclin-Dependent Kinases; Drug Design; Hydrogen Bonding; Isopentenyladenosine; Kinetics; Ligands; Models, Molecular; Molecular Structure; Protein Conformation; Purines; Roscovitine; Static Electricity | 2002 |
Cyclin-dependent kinase inhibitor, roscovitine, in combination with exogenous cytokinin, N6-benzyladenine, causes increase of cis-cytokinins in immobilized tobacco cells.
Topics: Adenine; Alginates; Benzyl Compounds; Cell Survival; Cells, Cultured; Cells, Immobilized; Cyclin-Dependent Kinases; Cytokinins; Glucuronic Acid; Hexuronic Acids; Isopentenyladenosine; Kinetin; Nicotiana; Purines; Reproducibility of Results; Roscovitine; Sensitivity and Specificity | 2003 |
Analysis of CDK2 active-site hydration: a method to design new inhibitors.
Topics: Adenine; Adenosine Triphosphate; Binding Sites; CDC2-CDC28 Kinases; Computer Simulation; Crystallography, X-Ray; Cyclin-Dependent Kinase 2; Drug Design; Enzyme Inhibitors; Hydrogen Bonding; Isopentenyladenosine; Models, Molecular; Protein Structure, Secondary; Purines; Roscovitine; Solvents; Static Electricity; Thermodynamics; Water | 2004 |